RBC Capital Markets initiates research coverage
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
RBC Capital
Cambridge, UK, 14 March 2025 - 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform, announces that RBC Capital Markets has initiated research coverage of the Company, which can be found on the Company’s website https://www.4basebio.com/investors/analyst-coverage/.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.